ArticleAnnals of internal medicine2022

In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival.

Alexandre Tran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.